The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein–1 in patients with type 2 diabetes complicated by hyperlipidemia

The effect of low-dose atorvastatin on various biomarkers was investigated in patients with type 2 diabetes complicated by hyperlipidemia. At 0 and 12 weeks in both the atorvastatin group (10 mg/d; n = 17) and the no-drug group (n = 10), high-sensitivity C-reactive protein (hsCRP), monocyte chemoatt...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Metabolism, clinical and experimental clinical and experimental, 2005-09, Vol.54 (9), p.1225-1229
Hauptverfasser:	Takebayashi, Kohzo, Matsumoto, Sachiko, Wakabayashi, Sadao, Inukai, Yoshihisa, Matsutomo, Rika, Aso, Yoshimasa, Inukai, Toshihiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Atorvastatin Calcium Biological and medical sciences C-Reactive Protein - metabolism Chemokine CCL2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - immunology Diabetes. Impaired glucose tolerance Disorders of blood lipids. Hyperlipoproteinemia Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Fibrinogen - metabolism Heptanoic Acids - administration & dosage Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage Hyperlipidemias - complications Hyperlipidemias - drug therapy Hyperlipidemias - immunology Inflammation - blood Inflammation - drug therapy Male Medical sciences Metabolic diseases Middle Aged Plasminogen Activator Inhibitor 1 - blood Pyrroles - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!